AI assistant
Sending…
ESSA Pharma Inc. — Director's Dealing 2024
Apr 25, 2024
35249_dirs_2024-04-25_7d3b4d02-c458-494a-8771-a908304e4225.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2024-04-24
Reporting Person: Glickman Richard M (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-04-24 | Common Shares | M | 3750 | $4.9 | Acquired | 43240 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-04-24 | Options | $4.9 | M | 3750 | Disposed | 2024-05-21 | Common Shares (3750) | Direct |
More from ESSA Pharma Inc.
Regulatory Filings
2025
Nov 17
Major Shareholding Notification
2025
Nov 14
Major Shareholding Notification
2025
Nov 14
Regulatory Filings
2025
Oct 28
Director's Dealing
2025
Oct 15
Director's Dealing
2025
Oct 15
Director's Dealing
2025
Oct 15
Director's Dealing
2025
Oct 15
Director's Dealing
2025
Oct 15
Director's Dealing
2025
Oct 15